Browsed by
Author: Kimberly Pena

Guns, America and the “Violence Inside Us”: US Senator Chris Murphy Explores Origins of the Nation’s Gun Culture and His Own Odyssey for Reform

Guns, America and the “Violence Inside Us”: US Senator Chris Murphy Explores Origins of the Nation’s Gun Culture and His Own Odyssey for Reform

This week, hosts Mark Masselli and Margaret Flinter speak with US Senator Chris Murphy of Connecticut, whose critically acclaimed new book examines America’s long, unique history of violence and its embedded gun culture. His book, “The Violence Inside Us: A Brief History of an Ongoing American Tragedy”, examines the birth and growth of America’s gun culture, the conditions that perpetuated it, and his quest to pass sane gun laws in response to the Sandy Hook School shooting.

National Pediatric Leader Talks About Returning To School In Pandemic

National Pediatric Leader Talks About Returning To School In Pandemic

This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Sara Goza, President of the American Academy of Pediatrics, the largest organization dedicated to advancing the physical, mental and social health of the nation’s infants, children and young adults. Dr. Goza discusses how pediatricians can help inform the tough decisions families are making to keep kids safe while sending them back to school, the vital importance of continued well-visits and vaccinations for kids, and the policy agenda being promoted…

Read More Read More

Pandemic XPrize Competition: Dr. Daniel Kraft on Quest to Leverage Tech and AI For Solutions to Address COVID-19

Pandemic XPrize Competition: Dr. Daniel Kraft on Quest to Leverage Tech and AI For Solutions to Address COVID-19

This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Daniel Kraft, physician-scientist, inventor, entrepreneur and Chair of the XPrize Pandemic Alliance Task Force, which is holding competitions to develop better tools for addressing COVID-19. Dr. Kraft, who is also founder and Executive Director of Exponential Medicine, looks at emerging developments that will lead to better rapid tests, masks as well as tech and AI-enabled interventions that will offer earlier diagnosis of infection, and better treatment and management of…

Read More Read More

Should I Send My Kids Back To School? Renowned Scientist Dr. William Haseltine Has Advice for Families

Should I Send My Kids Back To School? Renowned Scientist Dr. William Haseltine Has Advice for Families

This week, hosts Mark Masselli and Margaret Flinter speak with Dr. William Haseltine, President of ACCESS Health International, a global health think tank. He is also a renowned scientist, entrepreneur, philanthropist and founder of Harvard Medical School’s HIV/AIDS and cancer research centers. He discusses his two new books: A Family Guide to COVID: Questions and Answers for Parents, Grandparents and Children, and A COVID Back To School Guide which are continually-updating ‘living e-books’ offering answers to the many questions families…

Read More Read More

New York Times Science Reporter Apoorva Mandavilli On The Challenges of Covering COVID 19

New York Times Science Reporter Apoorva Mandavilli On The Challenges of Covering COVID 19

This week, hosts Mark Masselli and Margaret Flinter speak with New York Times Science and Global Health Reporter Apoorva Mandavilli, who has been covering emerging discoveries around the COVID-19 pandemic. She discusses the rapidly-evolving science on how this novel pathogen spreads, the guidelines for sending kids and teachers back into schools, and the rapid development of therapeutics and vaccines to treat and prevent infection.

COVID-19 Vaccines: When Will They Be Ready? Will They Work? Listen to Leading Expert Dr. Naor Bar-Zeev

COVID-19 Vaccines: When Will They Be Ready? Will They Work? Listen to Leading Expert Dr. Naor Bar-Zeev

This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Naor Bar-Zeev, Deputy Director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health. He examines the scientific guidelines governing COVID-19 vaccine phase 3 clinical trials, including a broad demographic representation to ensure vaccine safety across multiple populations, and the need to address vaccine hesitancy as well as the global supply chain needed to distribute billions of doses.